• Publications
  • Influence
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management
This paper is the first in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s diseaseExpand
  • 726
  • 41
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Principal changes with respect to the 2004 ECCO guidelines Ileocolonoscopy is recommended within the first year after surgery where treatment decisions may be affected (Statement 8C). ThiopurinesExpand
  • 794
  • 38
  • Open Access
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
BACKGROUND & AIMS Pouchitis is the major long-term complication after ileal pouch-anal anastomosis for ulcerative colitis. Most patients have relapsing disease, and no maintenance treatment study hasExpand
  • 1,386
  • 29
Modulation of human dendritic cell phenotype and function by probiotic bacteria
Background: “Probiotic” bacteria are effective in treating some inflammatory bowel diseases. However which bacteria confer benefit and mechanisms of action remain poorly defined. Dendritic cells,Expand
  • 528
  • 28
  • Open Access
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery,
aDepartment of Pharmacology and Therapeutics, University of Porto; MedInUP, Centre for Drug Discovery and Innovative Medicines; Centro Hospitalar São João, Porto, Portugal bIBD Unit, DIMEC,Expand
  • 518
  • 23
  • Open Access
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
BACKGROUND AND AIMS:Intestinal bacteria have been implicated in the initiation and perpetuation of IBD; in contrast, “probiotic bacteria” have properties possibly effective in treating and preventingExpand
  • 652
  • 22
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
Background: Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic preparationExpand
  • 813
  • 20
  • Open Access
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns treatment of active disease, maintenance of medically inducedExpand
  • 619
  • 18
  • Open Access
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
### 8.1 General Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the procedure of choice for most patients with ulcerative colitis (UC) requiring colectomy.1 Pouchitis is a non-specificExpand
  • 370
  • 17
  • Open Access
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.
A new therapeutic approach for inflammatory bowel diseases is based on the administration of probiotic bacteria. Prokaryotic DNA contains unmethylated CpG motifs which can activate immune responses,Expand
  • 278
  • 17